Compare Extra Space Storage, Inc. (EXR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs GeneDx Holdings Corp — how do they compare? Extra Space Storage, Inc. trades at $134.65 (market cap $28.12B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Extra Space Storage, Inc. is far larger — about 13.9× GeneDx Holdings Corp's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and GeneDx Holdings Corp for 19 Days on average.
| EXR | WGS | |
|---|---|---|
Market Cap | $28.12B | $2.02B |
Volume | 2,595,579 | 734,640 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $167.51 |
52-Week Low | $126.67 | $34.51 |
Typical Hold Time | 109 Days | 19 Days |
Enterprise Value | $41.84B | $2.05B |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $133.12, up 1.08% today, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38B in 2025, and net income margin remains healthy at 27.79%. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33 implying upside. Recent news highlights leadership transition and positive operational performance.
The outlook is balanced: solid profitability and growth support upside, but high valuation multiples and bearish technicals pose near-term risks. Key catalysts include Q3 earnings and execution under new leadership. Risks involve interest rate sensitivity and competitive pressures in the REIT sector.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
